Video
Please note that the English version of this text has been prepared with the assistance of AI, and in some instances, it may not have been subsequently reviewed or edited by the authors.
Description
Artificial oxygen carriers have been pursued for decades as a potential alternative to donor blood. They could play a transformative role in disaster relief, remote regions with limited blood supply, and veterinary care.
SHOC focuses on improving the pharmacokinetic performance of hemoglobin-based oxygen carriers by extending their circulation time in the bloodstream. Through advanced polymer surface engineering, we aim to enhance their stability and therapeutic potential.
The Achievable Results
Develop advanced hemoglobin-based artificial oxygen carriers with extended circulation time and enhanced stability using advanced polymer surface engineering approaches.
The Anticipated Benefit
Provide a safer and more accessible alternative to donor blood, especially in emergency situations, remote regions, and veterinary medicine.
The Allocated Funding
190,000 EUR on 03/01/2026.
Team
Dr. Baiba Švalbe
Senior Researcher 
Dr. Mingjia Chen
Researcher Gallery
